We read with interest the paper by Kok et al1. It concludes that prediabetes mellitus (pDM) imposes a higher risk of major adverse cardiovascular events (MACE) than normoglycaemia (NG) in patients, two thirds with acute coronary syndrome (ACS), undergoing coronary stenting.
pDM was defined on the basis of HbA1c and fasting plasma glucose (FPG). In the absence of two-hour post-load glucose (2 hr-PG), it is unclear as to how many of the pDM patients had impaired glucose tolerance (IGT) or DM. It is widely accepted that FPG and HbA1c underdiagnose DM and do not diagnose IGT2,3. The ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com